Indivior reported 122M in Ordinary Share Capital for its fiscal semester ending in March of 2026.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 44K Jun/2026
Cassava Sciences USD 48.31M 0 Mar/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Glaxosmithkline GBP 4.05B 20.6M Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Roche Holding CHF 796.77M 1.15M Jun/2026
West Pharmaceutical Services USD 70.4M 500K Jun/2026